SCHEMBL21292833

SCHEMBL21292833

CCNC(=S)NN=Cc1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 5/20 0.85
MAPT P10636 7/20 0.72
ALDH1A1 P00352 6/20 0.72
KDM4E B2RXH2 5/20 0.72
MEN1 O00255 5/20 0.72
KMT2A Q03164 5/20 0.72
POLB P06746 4/20 0.72
TDP1 Q9NUW8 3/20 0.72
PKM P14618 3/20 0.72
GAA P10253 2/20 0.72
L3MBTL1 Q9Y468 2/20 0.72
RECQL P46063 1/20 0.72
CTDSP1 Q9GZU7 1/20 0.72
HPGD P15428 3/20 0.65
ALOX12 P18054 2/20 0.65
LMNA P02545 2/20 0.65
NPSR1 Q6W5P4 1/20 0.61
NPC1 O15118 2/20 0.57
RAB9A P51151 1/20 0.57
USP2 O75604 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20115633 1.00 PHGDH (0.85) PHGDHMAPTALDH1A1KDM4EMEN1
SCHEMBL29599198 0.92 PHGDH (1.00) PHGDHMAPTALDH1A1KDM4EMEN1
SCHEMBL21292756 0.92 PHGDH (1.00) PHGDHMAPTALDH1A1KDM4EMEN1
SCHEMBL20115468 0.92 PHGDH (1.00) PHGDHMAPTALDH1A1KDM4EMEN1
SCHEMBL24767664 0.92 PHGDH (1.00) PHGDHMAPTALDH1A1KDM4EMEN1
SCHEMBL28369669 0.90 PHGDH (0.69) PHGDHMAPTALDH1A1KDM4EMEN1
SCHEMBL28369671 0.90 PHGDH (0.69) PHGDHMAPTALDH1A1KDM4EMEN1
SCHEMBL4455860 0.87 PHGDH (0.77) PHGDHMAPTALDH1A1KDM4EMEN1
SCHEMBL13886982 0.87 PHGDH (0.77) PHGDHMAPTALDH1A1KDM4EMEN1
SCHEMBL21292810 0.83 PHGDH (1.00) PHGDHMAPTALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD PHGDH 4/4885MAPT 3785/4885ALDH1A1 447/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885MAPT 3785/4885ALDH1A1 447/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885MAPT 3785/4885ALDH1A1 447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.